Limits...
Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, Israel.

Stienlauf S, Yahalom V, Schwartz E, Shinar E, Segal G, Sidi Y - Emerging Infect. Dis. (2009)

Bottom Line: The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons.In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively.HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.

View Article: PubMed Central - PubMed

Affiliation: Sheba Medical Center, Tel Hashomer, Israel. sshmuel@netvision.net.il

ABSTRACT
The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.

Show MeSH

Related in: MedlinePlus

Relative risk for human T-cell lymphotropic virus type 1 carriage in donors from different geographic origins. Odds ratios (indicated by black boxes) are charted in logarithmic scale. Error bars indicate 95% confidence intervals (CI). *Per 100,000 population; †p<0.05.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC2744246&req=5

Figure 2: Relative risk for human T-cell lymphotropic virus type 1 carriage in donors from different geographic origins. Odds ratios (indicated by black boxes) are charted in logarithmic scale. Error bars indicate 95% confidence intervals (CI). *Per 100,000 population; †p<0.05.

Mentions: ORs for HTLV-1 carriers varied by geographic origin of donor (Figure 2). Donors from Middle Eastern and Eastern European countries were at highest risk for HTLV-1 carriage.


Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, Israel.

Stienlauf S, Yahalom V, Schwartz E, Shinar E, Segal G, Sidi Y - Emerging Infect. Dis. (2009)

Relative risk for human T-cell lymphotropic virus type 1 carriage in donors from different geographic origins. Odds ratios (indicated by black boxes) are charted in logarithmic scale. Error bars indicate 95% confidence intervals (CI). *Per 100,000 population; †p<0.05.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC2744246&req=5

Figure 2: Relative risk for human T-cell lymphotropic virus type 1 carriage in donors from different geographic origins. Odds ratios (indicated by black boxes) are charted in logarithmic scale. Error bars indicate 95% confidence intervals (CI). *Per 100,000 population; †p<0.05.
Mentions: ORs for HTLV-1 carriers varied by geographic origin of donor (Figure 2). Donors from Middle Eastern and Eastern European countries were at highest risk for HTLV-1 carriage.

Bottom Line: The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons.In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively.HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.

View Article: PubMed Central - PubMed

Affiliation: Sheba Medical Center, Tel Hashomer, Israel. sshmuel@netvision.net.il

ABSTRACT
The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.

Show MeSH
Related in: MedlinePlus